Steatotic liver disease in patients with chronic hepatitis C

Table 7 Factors associated with treatment failure in multivariate analysis

Effect	Effect measure	OR	95%CI	P value
Intercept		0.001	< 0.001-0.007	< 0.0001
Gender	Male	6.962	0.851-56.938	0.0704
GT3 infection	Yes	3.986	1.206-13.182	0.0234
History of previous therapy	Experienced	3.054	0.764-12.206	0.1142
Fibrosis	4	6.716	1.80-25.062	0.0046
BMI	≥ 30 kg/m2	0.684	0.168-2.787	0.5958
SLD	Yes	2.505	0.488-12.859	0.2712

OR: Odds ratio; CI: Confidence interval; GT: Genotype; BMI: Body mass index; SLD: Steatotic liver disease.